Department of Emergency Medicine, SUNY Upstate Medical University, Syracuse, New York.
Department of Sports Performance, Sports Medicine, Colgate University, Hamilton, New York; and.
Clin J Sport Med. 2022 Jul 1;32(4):382-386. doi: 10.1097/JSM.0000000000001043. Epub 2022 Jun 1.
The objective of this study was to determine the utility of "standard" cardiac screening with EKG, echocardiography, and serum troponin T (hs-Tn T) testing after COVID infection in competitive college athletes.
Prospective cohort study.
Tertiary cardiology clinic, university training room.
Sixty-five Division 1 athletes recovered from COVID-19 and 465 controls.
All COVID-recovered athletes underwent cardiac screening on return to campus in fall 2020. Controls were screened if indicated by preparticipation examination. Students cleared for sports participation were followed for the development of cardiac complications.
Incidence of cardiac complications after COVID infection.
Infected athletes experienced mild (26/65), moderate (8/65), or no (31/65) COVID symptoms. No athletes had severe symptoms. Men were more likely to have been asymptomatic (20/31), and women were more likely to have had moderate (7/8) symptoms (P = 0.015). All athletes, except 2 with anosmia, were asymptomatic at the time of cardiac testing. One athlete had persistently elevated hs-Tn T but no evidence of myocarditis on cardiac MRI. All other cardiac testing was negative. No athletes were diagnosed with myocarditis (95% CI: 0%-5.5%). All athletes were cleared for athletic participation. None suffered complications over the next 9 months.
After COVID-19 infection, no college athletes with mild, moderate, or no symptoms had signs of myocarditis, and all returned to play without cardiac complication. These findings support consensus opinion recommendations that college-age athletes who recovered from COVID-19 and who experienced mild or no symptoms may return to play without cardiac testing.
本研究旨在确定在 COVID 感染后,对竞技性大学生运动员进行心电图(EKG)、超声心动图和血清肌钙蛋白 T(hs-TnT)“标准”心脏筛查的效用。
前瞻性队列研究。
三级心脏病学诊所、大学训练室。
65 名从 COVID-19 中康复的一级运动员和 465 名对照者。
2020 年秋季,所有 COVID 康复运动员在返回校园时都接受了心脏筛查。如果参加预参赛检查有指征,对照组也接受了筛查。清除运动参与的学生随访心脏并发症的发生情况。
COVID 感染后心脏并发症的发生率。
感染运动员经历了轻度(26/65)、中度(8/65)或无(31/65)COVID 症状。没有运动员出现严重症状。男性更有可能无症状(20/31),而女性更有可能出现中度症状(7/8)(P=0.015)。除了 2 名嗅觉丧失者外,所有运动员在心脏检查时都无症状。一名运动员 hs-TnT 持续升高,但心脏 MRI 未见心肌炎证据。所有其他心脏检查均为阴性。没有运动员被诊断为心肌炎(95%可信区间:0%-5.5%)。所有运动员均获准参加运动。在接下来的 9 个月中,没有运动员出现并发症。
在 COVID-19 感染后,没有出现轻度、中度或无症状的大学生运动员有心肌炎的迹象,所有运动员都恢复了运动,没有出现心脏并发症。这些发现支持了共识意见的建议,即从 COVID-19 中康复且经历轻度或无症状的大学生运动员可能无需进行心脏检查即可重返赛场。